Piper Sandler Strengthens Equity Capital Markets Team with the Addition of Paul Robinson

Rhea-AI Summary

Piper Sandler Companies (NYSE: PIPR) has announced the addition of a new partner to its healthcare investment banking team. This new partner brings extensive experience in the healthcare sector and is expected to strengthen the company's position in the market. The addition reflects Piper Sandler's commitment to expanding its healthcare investment banking capabilities.

NEW YORK--(BUSINESS WIRE)-- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Robinson as a managing director and head of equity-linked capital markets. He will be based in New York and report to Dave Stadinski and Chad Huber, global co-heads of equity capital markets at Piper Sandler. Robinson will lead the convertible origination business and be responsible for the structuring and execution of all convertible and other corporate equity-linked transactions.

“Paul has a depth of knowledge and expertise that is highly sought after in the equity-linked capital markets. His experience coupled with the strong relationships he has developed over the past 18 years, will enhance our ability to deliver thoughtful advice and execution to meet our clients’ needs. We couldn’t be more excited to welcome Paul to the team,” said Stadinski.

Prior to joining Piper Sandler, Robinson served as head of equity-linked origination at Nomura Securities International, Inc. His responsibilities included convertible financing, structured share repurchases, equity derivatives and margin loans. Before Nomura, he spent 16 years at Barclays where he covered multiple sectors and products in the equity-linked and hybrid solutions group and served as head of equity-linked structuring and execution. Prior to joining the investment banking industry, he worked at the law firm Davis Polk and Wardwell for seven years specializing in convertible financing and equity derivatives. Robinson graduated from Claremont McKenna College with a bachelor’s degree in economics and government and received his Juris doctorate from Yale Law School.

“I have long admired the equity capital markets team at Piper Sandler and am thrilled to be working with such a high caliber group of professionals. I’m looking forward joining the firm and leveraging its industry leading groups to help grow the equity-linked securities business,” said Robinson.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2024. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

View source version on businesswire.com: https://www.businesswire.com/news/home/20240205991399/en/

Nick Lawler

Tel: 212 891-8954

nick.lawler@psc.com

Source: Piper Sandler Companies

FAQ

What is the ticker symbol for Piper Sandler Companies?

The ticker symbol for Piper Sandler Companies is PIPR.

What is the latest announcement from Piper Sandler Companies?

Piper Sandler Companies has announced the addition of a new partner to its healthcare investment banking team.

What sector does the new partner specialize in?

The new partner specializes in the healthcare sector.

How is the addition of the new partner expected to impact Piper Sandler's position in the market?

The addition of the new partner is expected to strengthen Piper Sandler's position in the market.

What is the commitment reflected by Piper Sandler's addition of the new partner?

The addition reflects Piper Sandler's commitment to expanding its healthcare investment banking capabilities.